|
Thyroid Dysfunction and Its Association With Metabolic Dysfunction-Associated Fatty Liver Disease
RECRUITINGSponsored by Tanta University
Actively Recruiting
SponsorTanta University
Started2024-12-19
Est. completion2025-05-01
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06739330
Summary
This study aims to evaluate the prevalence of thyroid dysfunction and its association with metabolic dysfunction-associated fatty liver disease.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * Age ≥ 18 years. * Both sexes. * Patients with metabolic dysfunction-associated fatty liver disease (MAFLD). Exclusion Criteria: * History of thyroid disease or treatment (e.g., thyroid nodules, thyroid cancer, hypothyroidism, and hyperthyroidism). * Patients with alcoholic liver disease take more than 40g of alcohol (or four units) per day. * Viral hepatitis. * Pregnant women.
Conditions3
Liver DiseaseMetabolic Dysfunction-associated Fatty Liver DiseaseThyroid Dysfunction
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorTanta University
Started2024-12-19
Est. completion2025-05-01
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06739330